Efficacy and Toxicity of Panitumumab After Progression on Cetuximab and Predictive Value of MiR-31-5p in Metastatic Wild-type KRAS Colorectal Cancer Patients.
暂无分享，去创建一个
A. Poprach | Z. Bortlíček | T. Buchler | O. Slabý | M. Svoboda | J. Drabek | J. Mlčochová | A. Ryška | P. Vychytilová-Faltejsková | I. Kiss | S. Batko | M. Hajdůch | J. Drábek